M&G PLC

Position in GILD — Gilead Sciences, Inc.

CIK 1802539 London, X0

Position in GILD

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$9,921,101

-$3,424,552 QoQ

Shares Held

78,527

-18.0% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#435

of 2,275 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

M&G PLC holds $1,479,850,248 across 11 Drug Manufacturers - General names. GILD ranks #8 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	4,482,712	$850,011,848
2	BMY	Bristol Myers Squibb Co	5,292,229	$304,938,234
3	ABBV	AbbVie Inc.	579,447	$145,812,043
4	AMGN	Amgen Inc	289,819	$104,949,256
5	MRK	Merck & Co., Inc.	210,965	$27,109,002
6	JNJ	Johnson & Johnson	52,505	$13,334,694
7	PFE	Pfizer Inc	418,626	$10,080,514
8	GILD	Gilead Sciences, Inc. This page	78,527	$9,921,101

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,921,101	78,527	-18.0%	Shares	Defined	2026-08-06
2026-03-31	$13,345,653	95,757	-6.5%	Shares	Defined	2026-05-13
2025-12-31	$12,574,222	102,446	+5.1%	Shares	Defined	2026-02-12
2025-09-30	$10,822,944	97,504	-6.6%	Shares	Defined	2025-11-07
2025-06-30	$11,571,280	104,368	-22.6%	Shares	Sole	2025-08-08
2025-03-31	$15,110,838	134,858	-9.6%	Shares	Sole	2025-05-13
2024-12-31	$13,782,527	149,210	-13.5%	Shares	Sole	2025-02-11
2024-09-30	$14,468,101	172,568	+11.5%	Shares	Sole	2024-10-31
2024-06-30	$10,615,133	154,717	+59.5%	Shares	Sole	2024-07-16
2024-03-31	$7,105,836	97,008	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.